Raising the bar in liver cancer therapypharmaphorum interviews professor Jeff Evans, from the University of Glasgow’s Institute of Cancer Sciences, about findings of a Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Bayer’s Stivarga fast-tracked for liver cancer reviewBayer’s cancer treatment Stivarga has been granted priority review status by the FDA for use as a second Share XBayer’s Stivarga fast-tracked for liver cancer reviewhttps://pharmaphorum.com/news/bayers-stivarga-fast-tracked-liver-cancer-review/
NICE says no to liver cancer drug NexavarLiver cancer treatment latest earmarked for removal from CDF Share XNICE says no to liver cancer drug Nexavarhttps://pharmaphorum.com/news/nice-says-no-liver-cancer-drug-nexavar/